ACTION OF PTH-RELATED PROTEIN ON THE GUT

$166,037P01FY2009DKNIH

University Of Texas Med Br Galveston, Galveston TX

Investigators

Linked publications & trials

Paper 31091220 Paper 26495794 Paper 26141517 Paper 25799526 Paper 25035110 Paper 24586530 Paper 23499802 Paper 23429583 Paper 22859298 Paper 22850625 Paper 22672542 Paper 22280800 Paper 22212451 Paper 22161860 Paper 21745389 Paper 21508335 Paper 21454444 Paper 21400030 Paper 21330944 Paper 21124211 Paper 20716917 Paper 20637541 Paper 20032390 Paper 19922946 Paper 19907321 Paper 19661333 Paper 19660504 Paper 19631696 Paper 19631337 Paper 19616583 Paper 19582519 Paper 19336516 Paper 19137015 Paper 19114032 Paper 19075230 Paper 19059215 Paper 19051360 Paper 19028687 Paper 18818315 Paper 18753628 Paper 18694729 Paper 18408738 Paper 18388186 Paper 18376306 Paper 18367654 Paper 18339306 Paper 18278068 Paper 18095163 Paper 18048355 Paper 17964713 Paper 17916648 Paper 17699782 Paper 17689699 Paper 17689694 Paper 17481480 Paper 17401458 Paper 17391779 Paper 17383815 Paper 17379415 Paper 17276526 Paper 17068197 Paper 17060400 Paper 17055458 Paper 17034759 Paper 17000667 Paper 16999977 Paper 16984735 Paper 16904986 Paper 16901989 Paper 16899224 Paper 16827123 Paper 16772787 Paper 16632996 Paper 16507986 Paper 16462766 Paper 16421204 Paper 16412560 Paper 16306192 Paper 16278684 Paper 16153452 Paper 16153451 Paper 16052516 Paper 16051276 Paper 15927696 Paper 15887120 Paper 15849504 Paper 15849193 Paper 15711891 Paper 15706438 Paper 15685558 Paper 15623535 Paper 15539432 Paper 15358593 Paper 15300220 Paper 15300173 Paper 15166955 Paper 15123666 Paper 15065019 Paper 15065018 Paper 15028947

Abstract

The overall hypothesis addressed in this project is that the gastrointestinal (Gl) peptide parathyroid hormone-related protein (PTHrP) plays an important regulatory role in the gut, and its dysregulation contributes to disease via aberrant regulation of the phosphatidylinositol-3-kinase (PI3K) pathway. We show that PTHrP increases colon cancer cell xenograft growth in vivo. PTHrP expression is higher in metastatic vs. non-metastatic colon cancer cells, and there is a direct correlation of PTHrP levels with pro-invasive integrin expression and the migratory and invasive potential of these cells in vitro. We find that the PI3K pathway mediates these effects. The focus of this project is to understand the molecular mechanisms via which PTHrP promotes colon cancer cell invasion, by pursuing three Aims. (1) The mechanism(s) governing the upregulation of PI3K by PTHrP will be determined, by asking whether this occurs via an interaction between the PI3K p85<x subunit with an activated PTHrP receptor, and/or is secondary to the PTHrP-mediated upregulation of integrin a6p4. PI3K activity will be measured after exogenous addition of PTHrP to the cell culture, and in cells engineered by stable transfection to overexpress PTHrP. The role of integrins in PI3K activation will be determined using siRNAs to downregulate their expression. (2) The role of downstream effectors regulated by PI3K, including Akt, PTEN, and the small GTP-binding proteins Rac and Cdc42, will be investigated. This aim will be accomplished using such techniques as transfection with dominant-negative mutants, determination of the protein levels by Western immunoblotting and immunocytochemistry, and direct activity measurements. (3) The pathway(s) via which PTHrP upregulates pro-invasive integrin expression will be addressed using Northern blot analysis to detect changes in integrin mRNA levels, pulse-chase analysis to detect alterations in the rate of integrin synthesis and turnover, and FACS analysis to detect changes in integrin intracellular mobilization in PTHrP-overexpressing vs. control colon cancer cells. These studies will allow us to identify the mechanism(s) by which PTHrP promotes invasion and metastases of colon cancer cells, and should ultimately allow the development of new therapeutic strategies aimed at controlling this process.

View original record on NIH RePORTER →